EKTAY Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 май 2024 @ 22:09):

Stats
Объем за сегодня	18 529.00
Средний объем	9 483.00
Рыночная капитализация	2.74B
EPS	$0 ( 2024-03-01 )
Дата следующего отчета о доходах	( $0 ) 2024-05-23
Last Dividend	$0.117 ( 2023-08-25 )
Next Dividend	$0 ( N/A )
P/E	20.66
ATR14	$0.0230 (0.33%)

Elekta AB (publ) Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Elekta AB (publ) Финансовые показатели

Annual	2023
Выручка:	$16.87B
Валовая прибыль:	$6.35B (37.64 %)
EPS:	$2.47

FY	2023
Выручка:	$16.87B
Валовая прибыль:	$6.35B (37.64 %)
EPS:	$2.47

FY	2022
Выручка:	$14.55B
Валовая прибыль:	$5.44B (37.37 %)
EPS:	$3.02

FY	2021
Выручка:	$13.76B
Валовая прибыль:	$5.61B (40.76 %)
EPS:	$3.28

Financial Reports:

No articles found.

Elekta AB (publ) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.118 (N/A)	$0 (N/A)	$0.118 (N/A)	$0 (N/A)	$0.117 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Elekta AB (publ) Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.43 - Stable (8.66%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.305	2013-09-04
Last Dividend	$0.117	2023-08-25
Next Dividend	$0	N/A
Payout Date	2023-09-15
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	$1.985	--
Avg. Dividend % Per Year	0.00%	--
Score	3.91	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.43
Div. Directional Score	9.09	--

Next Divdend (Est)
(2024-10-03)

$0.123 Estimate 7.07 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.91

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
UMICY	Ex Dividend Junior	2023-08-18	Annually	0.00%
KAEPF	Ex Dividend Junior	2023-09-28	Annually	0.00%
BTDPY	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
RWWI	Ex Dividend Knight	2023-06-02	Quarterly	0.00%
FGFH	Ex Dividend Knight	2023-08-07	Quarterly	0.00%
WTBFB	Ex Dividend Junior	2023-09-07	Quarterly	0.00%
MAORF	Ex Dividend Junior	2023-08-17	Sporadic	0.00%
CLLNY	Ex Dividend Junior	2023-06-16	Semi-Annually	0.00%
SONVY	Ex Dividend Knight	2023-06-14	Annually	0.00%
HBSI	Ex Dividend Knight	2023-07-27	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0786	1.500	8.43	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0466	1.200	8.45	10.00	[0 - 0.3]
returnOnEquityTTM	0.141	1.500	9.54	10.00	[0.1 - 1]
payoutRatioTTM	0.640	-1.000	3.60	-3.60	[0 - 1]
currentRatioTTM	1.095	0.800	9.53	7.62	[1 - 3]
quickRatioTTM	0.822	0.800	9.87	7.90	[0.8 - 2.5]
cashRatioTTM	0.181	1.500	-0.104	-0.156	[0.2 - 2]
debtRatioTTM	0.198	-1.500	6.70	-10.00	[0 - 0.6]
interestCoverageTTM	6.24	1.000	8.80	8.80	[3 - 30]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.98	2.00	8.01	10.00	[0 - 20]
debtEquityRatioTTM	0.593	-1.500	7.63	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.377	1.000	7.04	7.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.129	1.000	9.41	9.41	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.516	1.000	8.25	8.25	[0.2 - 2]
assetTurnoverTTM	0.593	0.800	9.38	7.50	[0.5 - 2]
Total Score				12.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.47	1.000	8.03	0	[1 - 100]
returnOnEquityTTM	0.141	2.50	9.70	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.98	2.00	8.67	10.00	[0 - 30]
dividendYielPercentageTTM	0.167	1.500	5.82	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.21	2.00	7.26	10.00	[0 - 30]
payoutRatioTTM	0.640	1.500	3.60	-3.60	[0 - 1]
pegRatioTTM	-0.103	1.500	-4.02	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.172	1.000	8.20	0	[0.1 - 0.5]
Total Score				5.43

Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.